RAB11A involves the regulation of the Wnt/β-catenin pathway to promote the deterioration of prostate cancer, and RAB5A upregulation is related with the proliferation invasion and EMT of ovarian cancer [15, 27]. Here, RAB11A is linked to prostate carcinoma.